Invest in ME Conference 12: First Class in Every Way
OverTheHills wraps up our series of articles on this year's 12th Invest in ME International Conference (IIMEC12) in London with some reflections on her experience as a patient attending the conference for the first time.
Discuss the article on the Forums.

New mitochondrial disease clue found

Discussion in 'Other Health News and Research' started by taniaaust1, Aug 21, 2011.

  1. taniaaust1

    taniaaust1

    Messages:
    11,870
    Likes:
    12,533
    Sth Australia
    for more on this, see http://news.ninemsn.com.au/article.aspx?id=8287707
     
  2. Annikki

    Annikki

    Messages:
    30
    Likes:
    1
    A strange coincidence

    An article which appeared in Nature Biochemistry Journal a few weeks ago mentions Lycera is working on a drug to inhibit mitochondrial ATPases to treat autoimmune diseases:

    Ken Garber

    Nature Biotechnology
    doi:10.1038/nbt0811-679

    Published online
    05 August 2011

    Galvanized by ex-Pfizer researchers, Lycera is pursuing allosteric inhibitors of the mitochondrial ATPase and a nuclear receptor in autoimmune and inflammatory diseases.
    http://www.nature.com/nbt/journal/v29/n8/full/nbt0811-679.html
     

See more popular forum discussions.

Share This Page